Analysis of the risk factors for the recurrence of cervical cancer following ovarian transposition

Purpose: To investigate the potential risk factors related to the recurrence of cervical cancer following ovarian transposition. Materials and Methods: A total of 105 patients with cervical carcinoma were retrospectively analyzed. Each patient underwent surgical therapy in combination with ovarian transposition from September 2000 to November 2009. The potential risk factors for recurrence following ovarian transposition were analyzed. Results: The average age of the 105 patients was 38.7 years. Twelve patients were in Stage IA, 65 in IB, 12 in Stage IIA, and 16 in Stage IIB. Twenty-five patients had well-differentiated cancer (G1). Fortyeight patients had moderately-differentiated cancer (G2), and 32 patients had poorly-differentiated cancer (G3). Ninety-seven cases were squamous cell carcinoma, three were adenocarcinoma, four were small cell carcinoma, and one case was adenosquamous carcinoma. Five patients (4.8%) had a recurrence, two of whom (1.9%) had ovarian metastasis. Univariate analysis showed that the pathological type (p = 0.005) and degree of differentiation (p = 0.001) were potential risk factors for recurrence of cervical carcinoma following ovarian transposition. Cancer embolus in vessels or lymphatic metastasis was observed in four of the five patients who suffered a recurrence. Conclusion: Pathological type, differentiated degree, and cancer embolus in vessels or lymphatic metastasis were identified as potential risk factors for the recurrence of cervical carcinoma after ovarian transposition.

Cervical carcinoma; Ovarian transposition; Recurrence.

[1] Parkin D.M.: “The global health burden of infection – associated cancers in the year 2002”. Int. J. Cancer, 2006, 118, 3030.

[2] Wei Lihui: “Study on preservation of female function in therapy of cervical carcinoma”. Chin. J. Obstet. Gynecol., 2005, 40, 217.

[3] Chen Baohuan, Yan Qian, Lin Shuang, Wang Yajun, Fang Shilan. Protection of transposed ovary on ovarian function of patients with cervical carcinoma treated with radiotherapy. Chin. J. Clin. (Electronic Version), 2009, 3, 309.

[4] Pahisa J., Martínez-Román S., Martínez-Zamora M.A., Torné A., Caparrós X., Sanjuán A., Lejárcegui J.A.: “Laparoscopic ovarian transposition in patients with early cervical cancer”. Int. J. Gynecol. Cancer, 2008, 18, 584.

[5] Wang Jianliu, Zhang Xiaohong, Liang Xudong, Wang Shijun, Xing Huimei, Wei Lihui. Evaluation of transposed ovarian function in young women with cervical carcinoma. Chin. J. Obstet. Gynecol., 2006, 41, 229.

[6] Shimada M., Kigawa J., Nishimura R., Yamaguchi S., Kuzuya K., Nakanishi T. et al.: “Ovarian metastasis in carcinoma of the uterine cervix”. Gynecol. Oncol., 2006, 101, 234.

[7] Nakanishi T., Wakai K., Ishikawa H., Nawa A., Suzuki Y., Nakamura S., Kuzuya K.: “A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix”. Gynecol. Oncol., 2001, 82, 504.

[8] L'ubusk M., Kudela M., L'ubusk D., Machac S., Procházka M., Mícková I.: “The effectiveness and complications of ovarian transposition in young women with cervical carcinoma”. Ceska Gynekol., 2004, 69, 283.

[9] Morice P., Haie Meder C., Pautier P., Lhomme C., Castaigne D.: “Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix:report of two cases and surgical implications”. Gynecol. Oncol., 2001, 83, 605.

[10] Ishii K., Aoki Y., Takakuwa K., Tanaka K.: “Ovarian function after radical hysterectomy with ovarian reservation for cervical carcinoma”. J. Reprod. Med., 2001, 46, 347.

[11] Ling Yan, Li Shitong, Song Juan: “Clinical study on ovarian function in patients with cervical carcinoma receiving ovarian transposition”. Proc. Obstet. Gynecol., 2009, 18, 541.

[12] Delotte J., Ferron G., Kuei T.L., Mery E., Gladieff L., Querleu D.: “Laparoscopic management of an isolated ovarian metastasis on a transposed ovary in a patient treated for Stage IB1 adenocarcinoma of the cervix”. J. Minim. Invasive Gynecol., 2009, 16, 106.

[13] Shigematsu T., Ohishi Y., Fujita T., Higashihara J., Irie T., Hayashi T.: “Metastatic carcinoma in a transposed ovary after radical hysterectomy for a Stage 1B cervical adenosquamous cell carcinoma. Case report”. Eur. J. Gynaecol. Oncol., 2000, 21, 383.

[14] Ivanov S., Zervoudis S., Ivanov S.: “Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a Stage I B and II A cervical carcinoma”. Akush. Ginekol. (Sofiia) 2003, 42, 22.

[15] Yamamoto R., Okamoto K., Yukiharu T., Kaneuchi M., Negishi H., Sakuragi N., Fujimoto S.: “A study of risk factors for ovarian metastases in Stage Ib-IIb cervical carcinoma and analysis of ovarian function after a transposition”. Gynecol. Oncol., 2001, 82, 312.

[16] Zhang Meiqing, Chen Mingzhi: “Analysis of 174 cases with cervical carcinoma in women under 35 years old”. Chin. J. Obstet. Gynecol., 2003, 38, 689.

[17] Landoni F., Zanagnolo V., Lovato-Diaz L., Maneo A., Rossi R., Gadducci A. et al.: “Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)”. Int. J. Gynecol. Cancer, 2007, 17, 623.

[18] Huang K.G., Lee C.L., Tsai C.S., Han C.M., Hwang L.L.: “A new approach for laparoscopic ovarian transposition before pelvic irradiation”. Gynecol. Oncol., 2007, 105, 234.

[19] Plante M., Renaud M.C., François H., Roy M.: “Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature”. Gynecol. Oncol., 2004, 94, 614.

[20] Sanjuán A., Martínez Román S., Martínez-Zamora M.A., Pahisa J.: “Bilateral ovarian metastasis on transposed ovaries from cervical carcinoma”. Int. J. Gynaecol. Obstet., 2007, 99, 64.

[21] Li Ziting, Zhang Zhiyi. Progress and management strategies of cervical carcinoma. Continuing Med. Educ., 2005, 19, 46.